Valuation Mabpharm Limited

Stocks

Market Closed - Hong Kong S.E. Other stock markets 04:08:05 2026-07-24 EDT			5-day change	1st Jan Change
0.4100 ^HKD	0.00%		+1.23%	-18.00%

06-24	Mabpharm Limited Receives Approval for New Drug Application of CMAB807X (Denosumab Injection)	CI
06-09	Mabpharm Limited Receives Approval For New Drug Application Of CMAB807 Denosumab Injection From National Medical Products Administration	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	3,646	3,360	1,587	1,722	1,085	1,853
Change	-	-7.86%	-52.77%	8.51%	-36.99%	70.77%
Enterprise Value (EV) ¹	3,202	3,325	1,710	1,831	1,307	2,070
Change	-	3.84%	-48.58%	7.11%	-28.61%	58.37%
P/E	-19.7x	-11.5x	-7.53x	-8.23x	-8.48x	44.9x
PBR	4.14x	5.58x	3.96x	8.4x	12.2x	11.8x
PEG	-	-0.2x	0.3x	11.85x	0.2x	-0x
Capitalization / Revenue	160x	40.5x	28.4x	19.8x	4.2x	2.87x
EV / Revenue	141x	40.1x	30.6x	21x	5.06x	3.2x
EV / EBITDA	-21.8x	-12.7x	-9.31x	-12.2x	-19.8x	34.9x
EV / EBIT	-19.6x	-11.2x	-7.56x	-9.07x	-10.9x	431x
EV / FCF	-19.4x	-10x	-6.95x	-23.6x	-8.64x	18,952x
FCF Yield	-5.17%	-9.96%	-14.4%	-4.24%	-11.6%	0.01%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0448	-0.0707	-0.0511	-0.0508	-0.031	0.01
Distribution rate	-	-	-	-	-	-
Net sales ¹	22.78	82.88	55.92	87.16	258.2	646.1
EBITDA ¹	-147.2	-262.8	-183.7	-150.1	-65.94	59.28
EBIT ¹	-163.4	-297.5	-226.3	-202	-119.7	4.803
Net income ¹	-184.6	-291.7	-210.8	-209.4	-127.9	57.13
Net Debt ¹	-444.5	-35.13	122.7	109.2	222.2	217.5
Reference price ²	0.8841	0.8147	0.3848	0.4175	0.2631	0.4493
Nbr of stocks (in thousands)	4,124,080	4,124,080	4,124,080	4,124,080	4,124,080	4,124,080
Announcement Date	4/21/21	4/21/22	4/20/23	4/18/24	4/22/25	4/27/26

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
MABPHARM LIMITED	-	-	-	-	216M
ARGENX SE	33.56x	8.36x	25.84x	0.05%	57.28B
WUXI APPTEC CO., LTD.	20.68x	6.37x	13.94x	1.54%	54.99B
INSMED INCORPORATED	-41.86x	13.29x	-39.17x	-.--%	23.18B
BIONTECH SE	-17.88x	4.15x	-7.26x	-.--%	22.59B
WUXI BIOLOGICS (CAYMAN) INC.	25.74x	5.04x	13.35x	-.--%	20.46B
GENMAB A/S	24.54x	4.77x	15.5x	-.--%	17.56B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-523.64x	37.41x	-1539.29x	-.--%	15.67B
PHARMAESSENTIA CORPORATION	43.58x	17.61x	45.34x	0.08%	14.46B
EXELIXIS, INC.	17.42x	5.04x	11.77x	-.--%	13.92B
Average	-46.43x	11.34x	-162.22x	0.19%	24.03B
Weighted average by Cap.	-19.53x	9.70x	-89.86x	0.37%